Do analysts prefer BDMD or HSCS?

HeartSciences has a consensus target price of $8.00, suggesting a potential upside of 132.15%. Given HeartSciences' stronger consensus rating and higher probable upside, analysts clearly believe HeartSciences is more favorable than Baird Medical Investment. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Baird Medical Investment 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 HeartSciences 1 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00

Which has higher earnings & valuation, BDMD or HSCS?

Baird Medical Investment has higher revenue and earnings than HeartSciences. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Baird Medical Investment $22.54M 2.12 N/A N/A N/A HeartSciences N/A N/A -$9.14M -$3.94 N/A

Is BDMD or HSCS more profitable?

Baird Medical Investment's return on equity of 0.00% beat HeartSciences' return on equity. Company Net Margins Return on Equity Return on Assets Baird Medical Investment N/A N/A N/A HeartSciences N/A -358.60% -144.82%

Does the media prefer BDMD or HSCS?

In the previous week, Baird Medical Investment had 1 more articles in the media than HeartSciences. MarketBeat recorded 4 mentions for Baird Medical Investment and 3 mentions for HeartSciences. Baird Medical Investment's average media sentiment score of 0.94 beat HeartSciences' score of 0.29 indicating that Baird Medical Investment is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Baird Medical Investment 1 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive HeartSciences 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Do analysts recommend POCI or HSCS?

HeartSciences has a consensus target price of $8.00, suggesting a potential upside of 132.15%. Given HeartSciences' stronger consensus rating and higher possible upside, analysts clearly believe HeartSciences is more favorable than Precision Optics. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Precision Optics 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 HeartSciences 1 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00

Does the media favor POCI or HSCS?

In the previous week, Precision Optics had 1 more articles in the media than HeartSciences. MarketBeat recorded 4 mentions for Precision Optics and 3 mentions for HeartSciences. Precision Optics' average media sentiment score of 0.72 beat HeartSciences' score of 0.29 indicating that Precision Optics is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Precision Optics 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive HeartSciences 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Is PAVM or HSCS more profitable?

HeartSciences has a net margin of 0.00% compared to PAVmed's net margin of -10,794.64%. PAVmed's return on equity of -126.43% beat HeartSciences' return on equity. Company Net Margins Return on Equity Return on Assets PAVmed -10,794.64% -126.43% -25.49% HeartSciences N/A -358.60% -144.82%

Does the media prefer PAVM or HSCS?

In the previous week, PAVmed and PAVmed both had 3 articles in the media. PAVmed's average media sentiment score of 1.31 beat HeartSciences' score of 0.29 indicating that PAVmed is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment PAVmed 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive HeartSciences 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

HeartSciences (HSCS) Competitors

$3.45 +0.06 (+1.65%)

As of 11:18 AM Eastern

Compare

HSCS vs. BDMD, POCI, MLSS, PAVM, and SNWV

Should you buy HeartSciences stock or one of its competitors? HeartSciences's main competitors and comparable companies include Baird Medical Investment (BDMD), Precision Optics (POCI), Milestone Scientific (MLSS), PAVmed (PAVM), and Sanuwave Health (SNWV). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare equipment" industry.

How does HeartSciences compare to Baird Medical Investment?

Baird Medical Investment (NASDAQ:BDMD) and HeartSciences (NASDAQ:HSCS) are both small-cap healthcare companies, but which is the superior business? We will compare the two companies based on the strength of their profitability, earnings, valuation, risk, dividends, analyst recommendations, institutional ownership and media sentiment.

HeartSciences has a consensus target price of $8.00, suggesting a potential upside of 132.15%. Given HeartSciences' stronger consensus rating and higher probable upside, analysts clearly believe HeartSciences is more favorable than Baird Medical Investment.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Baird Medical Investment	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
HeartSciences	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

19.8% of Baird Medical Investment shares are held by institutional investors. Comparatively, 17.2% of HeartSciences shares are held by institutional investors. 78.9% of Baird Medical Investment shares are held by company insiders. Comparatively, 4.9% of HeartSciences shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Baird Medical Investment has a beta of -1.15, meaning that its share price is 215% less volatile than the broader market. Comparatively, HeartSciences has a beta of 1.85, meaning that its share price is 85% more volatile than the broader market.

Baird Medical Investment has higher revenue and earnings than HeartSciences.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Baird Medical Investment	$22.54M	2.12	N/A	N/A	N/A
HeartSciences	N/A	N/A	-$9.14M	-$3.94	N/A

In the previous week, Baird Medical Investment had 1 more articles in the media than HeartSciences. MarketBeat recorded 4 mentions for Baird Medical Investment and 3 mentions for HeartSciences. Baird Medical Investment's average media sentiment score of 0.94 beat HeartSciences' score of 0.29 indicating that Baird Medical Investment is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Baird Medical Investment	1 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
HeartSciences	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Baird Medical Investment's return on equity of 0.00% beat HeartSciences' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Baird Medical Investment	N/A	N/A	N/A
HeartSciences	N/A	-358.60%	-144.82%

Summary

Baird Medical Investment beats HeartSciences on 7 of the 11 factors compared between the two stocks.

How does HeartSciences compare to Precision Optics?

Precision Optics (NASDAQ:POCI) and HeartSciences (NASDAQ:HSCS) are both small-cap healthcare companies, but which is the superior stock? We will compare the two companies based on the strength of their media sentiment, profitability, valuation, risk, analyst recommendations, earnings, dividends and institutional ownership.

HeartSciences has a consensus target price of $8.00, suggesting a potential upside of 132.15%. Given HeartSciences' stronger consensus rating and higher possible upside, analysts clearly believe HeartSciences is more favorable than Precision Optics.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Precision Optics	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
HeartSciences	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

Precision Optics has higher revenue and earnings than HeartSciences. Precision Optics is trading at a lower price-to-earnings ratio than HeartSciences, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Precision Optics	$19.09M	2.51	-$5.78M	-$0.63	N/A
HeartSciences	N/A	N/A	-$9.14M	-$3.94	N/A

In the previous week, Precision Optics had 1 more articles in the media than HeartSciences. MarketBeat recorded 4 mentions for Precision Optics and 3 mentions for HeartSciences. Precision Optics' average media sentiment score of 0.72 beat HeartSciences' score of 0.29 indicating that Precision Optics is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Precision Optics	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
HeartSciences	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

HeartSciences has a net margin of 0.00% compared to Precision Optics' net margin of -17.03%. Precision Optics' return on equity of -37.47% beat HeartSciences' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Precision Optics	-17.03%	-37.47%	-19.96%
HeartSciences	N/A	-358.60%	-144.82%

Precision Optics has a beta of 0.32, indicating that its stock price is 68% less volatile than the broader market. Comparatively, HeartSciences has a beta of 1.85, indicating that its stock price is 85% more volatile than the broader market.

13.7% of Precision Optics shares are held by institutional investors. Comparatively, 17.2% of HeartSciences shares are held by institutional investors. 14.4% of Precision Optics shares are held by company insiders. Comparatively, 4.9% of HeartSciences shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Summary

Precision Optics beats HeartSciences on 8 of the 15 factors compared between the two stocks.

How does HeartSciences compare to Milestone Scientific?

HeartSciences (NASDAQ:HSCS) and Milestone Scientific (NYSE:MLSS) are both small-cap healthcare companies, but which is the superior investment? We will compare the two businesses based on the strength of their earnings, media sentiment, risk, dividends, profitability, analyst recommendations, institutional ownership and valuation.

HeartSciences has a beta of 1.85, indicating that its share price is 85% more volatile than the broader market. Comparatively, Milestone Scientific has a beta of 1.08, indicating that its share price is 8% more volatile than the broader market.

Milestone Scientific has higher revenue and earnings than HeartSciences. Milestone Scientific is trading at a lower price-to-earnings ratio than HeartSciences, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
HeartSciences	N/A	N/A	-$9.14M	-$3.94	N/A
Milestone Scientific	$9.42M	4.09	-$6.93M	-$0.04	N/A

In the previous week, HeartSciences had 3 more articles in the media than Milestone Scientific. MarketBeat recorded 3 mentions for HeartSciences and 0 mentions for Milestone Scientific. HeartSciences' average media sentiment score of 0.29 beat Milestone Scientific's score of 0.00 indicating that HeartSciences is being referred to more favorably in the media.

Company	Overall Sentiment
HeartSciences	Neutral
Milestone Scientific	Neutral

HeartSciences has a net margin of 0.00% compared to Milestone Scientific's net margin of -52.01%. Milestone Scientific's return on equity of -60.26% beat HeartSciences' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
HeartSciences	N/A	-358.60%	-144.82%
Milestone Scientific	-52.01%	-60.26%	-40.23%

17.2% of HeartSciences shares are owned by institutional investors. Comparatively, 5.8% of Milestone Scientific shares are owned by institutional investors. 4.9% of HeartSciences shares are owned by company insiders. Comparatively, 9.2% of Milestone Scientific shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

HeartSciences currently has a consensus target price of $8.00, indicating a potential upside of 132.15%. Milestone Scientific has a consensus target price of $1.00, indicating a potential upside of 135.29%. Given Milestone Scientific's stronger consensus rating and higher probable upside, analysts clearly believe Milestone Scientific is more favorable than HeartSciences.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
HeartSciences	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Milestone Scientific	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	3.00

Summary

Milestone Scientific beats HeartSciences on 8 of the 14 factors compared between the two stocks.

How does HeartSciences compare to PAVmed?

PAVmed (NASDAQ:PAVM) and HeartSciences (NASDAQ:HSCS) are both small-cap healthcare companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, analyst recommendations, valuation, dividends, risk, profitability, earnings and media sentiment.

In the previous week, PAVmed and PAVmed both had 3 articles in the media. PAVmed's average media sentiment score of 1.31 beat HeartSciences' score of 0.29 indicating that PAVmed is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
PAVmed	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
HeartSciences	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

19.9% of PAVmed shares are owned by institutional investors. Comparatively, 17.2% of HeartSciences shares are owned by institutional investors. 13.4% of PAVmed shares are owned by insiders. Comparatively, 4.9% of HeartSciences shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

PAVmed currently has a consensus price target of $56.00, suggesting a potential upside of 1,247.45%. HeartSciences has a consensus price target of $8.00, suggesting a potential upside of 132.15%. Given PAVmed's higher possible upside, equities analysts plainly believe PAVmed is more favorable than HeartSciences.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
PAVmed	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
HeartSciences	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

PAVmed has higher revenue and earnings than HeartSciences. HeartSciences is trading at a lower price-to-earnings ratio than PAVmed, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
PAVmed	$70K	474.97	$400K	-$16.05	N/A
HeartSciences	N/A	N/A	-$9.14M	-$3.94	N/A

HeartSciences has a net margin of 0.00% compared to PAVmed's net margin of -10,794.64%. PAVmed's return on equity of -126.43% beat HeartSciences' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
PAVmed	-10,794.64%	-126.43%	-25.49%
HeartSciences	N/A	-358.60%	-144.82%

PAVmed has a beta of 0.53, meaning that its share price is 47% less volatile than the broader market. Comparatively, HeartSciences has a beta of 1.85, meaning that its share price is 85% more volatile than the broader market.

Summary

PAVmed beats HeartSciences on 9 of the 12 factors compared between the two stocks.

How does HeartSciences compare to Sanuwave Health?

HeartSciences (NASDAQ:HSCS) and Sanuwave Health (NASDAQ:SNWV) are both small-cap healthcare companies, but which is the better investment? We will compare the two businesses based on the strength of their media sentiment, dividends, earnings, valuation, institutional ownership, risk, profitability and analyst recommendations.

In the previous week, HeartSciences had 2 more articles in the media than Sanuwave Health. MarketBeat recorded 3 mentions for HeartSciences and 1 mentions for Sanuwave Health. Sanuwave Health's average media sentiment score of 1.87 beat HeartSciences' score of 0.29 indicating that Sanuwave Health is being referred to more favorably in the news media.

Company	Overall Sentiment
HeartSciences	Neutral
Sanuwave Health	Very Positive

HeartSciences has a beta of 1.85, meaning that its stock price is 85% more volatile than the broader market. Comparatively, Sanuwave Health has a beta of 1.47, meaning that its stock price is 47% more volatile than the broader market.

Sanuwave Health has higher revenue and earnings than HeartSciences. HeartSciences is trading at a lower price-to-earnings ratio than Sanuwave Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
HeartSciences	N/A	N/A	-$9.14M	-$3.94	N/A
Sanuwave Health	$44.05M	0.82	$11.81M	$0.24	17.52

Sanuwave Health has a net margin of 32.38% compared to HeartSciences' net margin of 0.00%. Sanuwave Health's return on equity of 1,728.10% beat HeartSciences' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
HeartSciences	N/A	-358.60%	-144.82%
Sanuwave Health	32.38%	1,728.10%	39.04%

17.2% of HeartSciences shares are owned by institutional investors. Comparatively, 42.5% of Sanuwave Health shares are owned by institutional investors. 4.9% of HeartSciences shares are owned by company insiders. Comparatively, 14.4% of Sanuwave Health shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

HeartSciences currently has a consensus target price of $8.00, indicating a potential upside of 132.15%. Sanuwave Health has a consensus target price of $47.00, indicating a potential upside of 1,017.72%. Given Sanuwave Health's higher possible upside, analysts plainly believe Sanuwave Health is more favorable than HeartSciences.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
HeartSciences	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Sanuwave Health	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

Summary

Sanuwave Health beats HeartSciences on 11 of the 13 factors compared between the two stocks.

Get HeartSciences News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding HSCS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

HSCS vs. The Competition

Export

Metric	HeartSciences	Healthcare Equipment & Supplies Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$13.44M	$5.46B	$7.20B	$12.67B
Dividend Yield	N/A	1.80%	2.57%	11.71%
P/E Ratio	-0.87	25.19	275.02	25.43
Price / Sales	N/A	44.29	638.08	88.25
Price / Cash	N/A	33.03	28.42	34.96
Price / Book	49.23	6.01	10.32	6.23
Net Income	-$9.14M	$150.75M	$3.50B	$358.31M
7 Day Performance	-7.61%	-2.57%	-2.41%	-1.59%
1 Month Performance	67.28%	-3.13%	0.22%	-2.89%
1 Year Performance	14.49%	9.57%	24.17%	8.22%

HeartSciences Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
HSCS HeartSciences	2.2048 of 5 stars	$3.45 +1.7%	$8.00 +132.2%	+12.6%	$13.44M	N/A	N/A	10	Analyst Upgrade Short Interest Increase
BDMD Baird Medical Investment	1.3061 of 5 stars	$1.12 -1.8%	N/A	-55.1%	$48.12M	$22.54M	N/A	N/A
POCI Precision Optics	0.8233 of 5 stars	$4.45 +5.0%	N/A	-1.1%	$46.41M	$19.09M	N/A	80	Short Interest Decrease
MLSS Milestone Scientific	1.4296 of 5 stars	$0.46 +1.3%	$1.00 +115.6%	-24.7%	$41.17M	$9.42M	N/A	30
PAVM PAVmed	3.2938 of 5 stars	$5.35 +7.2%	$56.00 +946.7%	-66.8%	$39.90M	$70K	N/A	90	Positive News Short Interest Decrease Gap Up

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:HSCS) was last updated on 9/14/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

HeartSciences (HSCS) Competitors

HSCS vs. BDMD, POCI, MLSS, PAVM, and SNWV

How does HeartSciences compare to Baird Medical Investment?

Summary

How does HeartSciences compare to Precision Optics?

Summary

How does HeartSciences compare to Milestone Scientific?

Summary

How does HeartSciences compare to PAVmed?

Summary

How does HeartSciences compare to Sanuwave Health?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

HSCS vs. The Competition

HeartSciences Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

HeartSciences (HSCS) Competitors

HSCS vs. BDMD, POCI, MLSS, PAVM, and SNWV

How does HeartSciences compare to Baird Medical Investment?

Do analysts prefer BDMD or HSCS?

Do institutionals and insiders hold more shares of BDMD or HSCS?

Which has more volatility and risk, BDMD or HSCS?

Which has higher earnings & valuation, BDMD or HSCS?

Does the media prefer BDMD or HSCS?

Is BDMD or HSCS more profitable?

Summary

How does HeartSciences compare to Precision Optics?

Do analysts recommend POCI or HSCS?

Which has preferable earnings & valuation, POCI or HSCS?

Does the media favor POCI or HSCS?

Is POCI or HSCS more profitable?

Which has more risk & volatility, POCI or HSCS?

Do institutionals and insiders hold more shares of POCI or HSCS?

Summary

How does HeartSciences compare to Milestone Scientific?

Which has more volatility & risk, HSCS or MLSS?

Which has higher earnings & valuation, HSCS or MLSS?

Does the media refer more to HSCS or MLSS?

Is HSCS or MLSS more profitable?

Do insiders & institutionals hold more shares of HSCS or MLSS?

Do analysts rate HSCS or MLSS?

Summary

How does HeartSciences compare to PAVmed?

Does the media prefer PAVM or HSCS?

Do insiders and institutionals have more ownership in PAVM or HSCS?

Do analysts prefer PAVM or HSCS?

Which has better earnings and valuation, PAVM or HSCS?

Is PAVM or HSCS more profitable?

Which has more volatility & risk, PAVM or HSCS?

Summary

How does HeartSciences compare to Sanuwave Health?

Does the media favor HSCS or SNWV?

Which has more risk and volatility, HSCS or SNWV?

Which has stronger earnings and valuation, HSCS or SNWV?

Is HSCS or SNWV more profitable?

Do institutionals and insiders believe in HSCS or SNWV?

Do analysts recommend HSCS or SNWV?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

HSCS vs. The Competition

HeartSciences Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools